Scholarlink

Introduction <p>Available data on robotic ureteral reconstruction procedures is concentrated from high volume centers. To better understand generalizability of success, we used a network of healthcare organizations (HCOs) to evaluate surgical success following robotic-assisted pyeloplasty (RP), ureteral reimplantation (RR), and ureteroureterostomy/ureteroplasty (RU). </p> Methods <p>We searched the TriNetX database for adult (&gt;18 years old) patients undergoing RP, RR and RU. Our primary outcome was need for drain placement (nephrostomy or ureteral stent) from 4 weeks to 10 years postoperatively. We evaluated risk factors (RF) for drain placement (vascular disease, kidney disease, diabetes (DM), smoking history, radiation history, age, body mass index (BMI, kg/m^2)) using hazard ratios, with significance when 95% confidence interval does not include 1.0.</p> Results <p>Analyses were run in October 2024. There were 1,324 RP patients from 30 HCOs, 464 RR patients from 22 HCOs, and 875 RU patients from 27 HCOs. Respectively, 10.8%, 11.7%, and 7.9% of patients needed a drain. DM (HR 2.0 (1.04–3.68)), smoking (HR 2.2 (1.34–3.49)), and BMI &gt; 25 (HR 1.6 (1.07–2.34)) were RFs for drain placement following RP. DM (HR 2.8 (1.18–6.63)) was also a RF for RR patients. Radiation was a RF for both RR (HR 2.9 (1.03–8.09)) and RU (HR 3.7 (1.006–13.9)) patients. Age &gt; 50 years (HR 2.3 (1.16–4.49)) was a RF for RU patients.</p> Conclusions <p>We report outcomes of robotic ureteral reconstruction from a variety of HCOs. This data helps describe the real world experience of patients undergoing robotic upper urinary tract reconstruction.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Surgical success following robotic upper urinary tract reconstruction, results from a global network of healthcare organizations

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月8日

查看全文
  • Zachary J. Prebay,
  • Adam Schneider,
  • Sohan Shah,
  • Mauro Dispagna,
  • Mihir S. Shah

摘要

Introduction

Available data on robotic ureteral reconstruction procedures is concentrated from high volume centers. To better understand generalizability of success, we used a network of healthcare organizations (HCOs) to evaluate surgical success following robotic-assisted pyeloplasty (RP), ureteral reimplantation (RR), and ureteroureterostomy/ureteroplasty (RU).

Methods

We searched the TriNetX database for adult (>18 years old) patients undergoing RP, RR and RU. Our primary outcome was need for drain placement (nephrostomy or ureteral stent) from 4 weeks to 10 years postoperatively. We evaluated risk factors (RF) for drain placement (vascular disease, kidney disease, diabetes (DM), smoking history, radiation history, age, body mass index (BMI, kg/m^2)) using hazard ratios, with significance when 95% confidence interval does not include 1.0.

Results

Analyses were run in October 2024. There were 1,324 RP patients from 30 HCOs, 464 RR patients from 22 HCOs, and 875 RU patients from 27 HCOs. Respectively, 10.8%, 11.7%, and 7.9% of patients needed a drain. DM (HR 2.0 (1.04–3.68)), smoking (HR 2.2 (1.34–3.49)), and BMI > 25 (HR 1.6 (1.07–2.34)) were RFs for drain placement following RP. DM (HR 2.8 (1.18–6.63)) was also a RF for RR patients. Radiation was a RF for both RR (HR 2.9 (1.03–8.09)) and RU (HR 3.7 (1.006–13.9)) patients. Age > 50 years (HR 2.3 (1.16–4.49)) was a RF for RU patients.

Conclusions

We report outcomes of robotic ureteral reconstruction from a variety of HCOs. This data helps describe the real world experience of patients undergoing robotic upper urinary tract reconstruction.